AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study

RecruitingNAAges 18 Years - anyAllLondon Health Sciences Centre Research Institute โ€ฆ
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * 18 yrs or older * scheduled to undergo elective VATS segmental or lobar resection of the lung Exclusion Criteria: * Pulmonary function tests demonstrating forced expiratory volume in 1 second Forced Expiratory Volume (FEV1) \<50% predicted, FEV1 \<1.5L and/or diffusion lung capacity of carbon monoxide Lung Diffusion Test (DLCO) \<50% predicted * Patient receives an intraoperative pleurodesis * Conversion to open thoracotomy or mini thoracotomy intraoperatively. * Underlying cognitive disorder resulting in inability to complete activities of daily living.
๐Ÿ’Š

What it tests

  • early chest tube removal
๐Ÿ“

Where

1 site
London Health Sciences Centre
London, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy